Navigation Links
Hill-Rom Reports Fiscal First Quarter Results; Provides Second Quarter and Full Year Financial Outlook

BATESVILLE, Ind., Jan. 25, 2012 /PRNewswire/ -- Hill-Rom Holdings, Inc. (NYSE: HRC) announced final financial results for its fiscal first quarter ended December 31, 2011 and reiterated its outlook for 2012. Earnings per diluted share decreased 4 percent during the period to $0.53 from $0.55.  Prior period earnings included a non-recurring benefit of $0.03 per share due to the reinstatement of the Research and Development Tax Credit for a previous period.  Net income decreased to $33 million from $35 million over the same period.  

Hill-Rom's quarterly revenue of $381 million increased 2 percent compared to last year.  Domestic revenue increased 7 percent to $272 million, while revenue outside the United States decreased 9 percent to $109 million in the same period.  Foreign exchange rates did not materially impact revenue comparisons.

Management Comments"First quarter results were in line with our previously announced preliminary figures," stated John J. Greisch, President & CEO.  "Strong performance in our North America Acute Care business, where revenue increased 7 percent, was partially offset by declines in our Post Acute Care and International businesses.
Despite a challenging environment, we are confident in our ability to deliver our earnings outlook for the year through disciplined management of our cost structure as we demonstrated in the first quarter."

Financial and Operational Highlights

  • First quarter revenue highlights include:
  • North America Acute Care.  North America Acute Care revenue grew 7 percent to approximately $234 million.  Capital sales increased 11 percent primarily due to higher sales of patient support systems, which grew 13 percent.  Rental revenue declined 2 percent versus the prior year.
  • International.  International segment revenue, which excludes Canada, declined 7 percent to approximately $97 million, due primarily to declines in Latin America and European regions.
  • North America Post-Acute Care.  North America Post-Acute Care revenue declined 3 percent to approximately $51 million.  Capital sales increased 5 percent and rental revenue decreased 5 percent versus the prior year.  Extended care revenue growth was more than offset by a decline in our home care business versus the prior year.
  • First quarter operating cash flow was $62 million, compared to $24 million in the prior year.
  • The Company commercialized its new powered stretcher products which received Food and Drug Administration (FDA) 510k clearance last quarter.  
  • During the quarter, the Company announced an agreement to acquire Volker group for approximately $85 million.  The acquisition is expected to close within the first calendar quarter of 2012.

  • Please see the attached schedules for additional information, including condensed financial information, summary balance sheet, cash flow statement and segment sales summaries.  

    For a more complete review of Hill-Rom's results, please refer to our Quarterly Report on Form 10-Q for the quarter ended December 31, 2011, which will be filed later this week.

    Financial Guidance SummaryFor the second quarter of fiscal 2012, Hill-Rom expects constant currency revenue to be flat compared to the prior year and expects adjusted earnings of $0.53 to $0.55 per diluted share.  

    Hill-Rom expects full-year constant currency revenue growth of between 3 and 4 percent and adjusted earnings of $2.45 to $2.50 per diluted share.  If currency rates remain stable near recent levels, the Company expects revenue growth to be approximately 1 percentage point lower on a reported basis for both the second quarter and full year.  Cash flow from operations for the full year is expected to be approximately $290 to $300 million.

    Hill-Rom Holdings, Inc. routinely provides earnings per share results and guidance on an adjusted basis because the Company's management believes that the presentation provides useful information to investors.  These measures exclude strategic developments, special charges and the impact of significant litigation or other unusual events. Such items may be highly variable, difficult to predict and of a size that sometimes have substantial impact on the Company's reported operations for a period. Often, prospective quantification of such items is not feasible.  Management uses these measures internally for planning, forecasting and evaluating the performance of the business. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP.

    Additional assumptions and discussion will be provided during the Company's conference call to be held tomorrow morning.  Information to access the webcast is provided below.

    Conference Call Webcast and Replay The Company will sponsor a conference call and webcast for the investing public at 8:00 a.m. ET, on Thursday, January 26, 2012.  The webcast is available at or and will be archived on the Company's website for those who are unable to listen live. A replay of the call is also available through February 2, 2012 at 855-859-2056 (404-537-3406 International). Code 40811485 is needed to access the replay.

    ABOUT HILL-ROM HOLDINGS, INC. Hill-Rom is a leading worldwide manufacturer and provider of medical technologies and related services for the health care industry, including patient support systems, safe mobility and handling solutions, non-invasive therapeutic products for a variety of acute and chronic medical conditions, medical equipment rentals and information technology solutions.  Hill-Rom's comprehensive product and service offerings are used by health care providers across the health care continuum and around the world in hospitals, extended care facilities and home care settings to enhance the safety and quality of patient care.

    Hill-Rom…enhancing outcomes for patients and their caregivers.

    Disclosure Regarding Forward-Looking Statements Certain statements in this press release contain forward-looking statements, within the meaning of the Private Securities Litigation Reform Act of 1995, regarding the Company's future plans, objectives, beliefs, expectations, representations and projections.  The Company has tried, wherever possible, to identify these forward-looking statements using words such as "intend," "anticipate," "believe," "plan," "encourage," "expect," "may," "goal," "become," "pursue," "estimate," "strategy," "will," "projection," "forecast," "continue," "accelerate," "promise," "increase," "higher," "lower," "reduce," "improve," "expand," "progress," "potential" or the negative of those terms or other variations of them or by comparable terminology.  The absence of such terms, however, does not mean that the statement is not forward-looking.  It is important to note that forward-looking statements are not guarantees of future performance, and the Company's actual results could differ materially from those set forth in any forward-looking statements.  Factors that could cause actual results to differ from forward-looking statements include but are not limited to: the Company's dependence on its relationships with several large group purchasing organizations, whether the Company's new products are successful in the marketplace, impacts of healthcare reform, compliance with federal healthcare programs, collections of accounts receivable, compliance with FDA regulations, potential exposure to product liability or other claims, failure of the Company's announced or future strategic initiatives and restructuring and realignment activities to achieve expected growth, efficiencies or cost reductions, failure of the Company to execute its acquisition and business alliance strategy through the consummation and successful integration of acquisitions or entry into joint ventures or other business alliances, increased costs or unavailability of raw materials, adverse changes in global economic conditions or disruptions of credit markets, labor disruptions, the ability to retain executive officers and other key personnel, and certain tax-related matters.  For a more in depth discussion of these and other factors that could cause actual results to differ from those contained in forward-looking statements, see the discussions under the heading "Risk Factors" in the Company's previously filed most recent Annual Report on Form 10-K and subsequent Quarterly Reports on Form 10-Q.  The Company assumes no obligation to update or revise any forward-looking statements.Hill-Rom Holdings, Inc. and Subsidiaries Condensed Consolidated Statements of Income (Dollars in millions except per share data) Quarterly Period Ended December 31 2011 2010 Net revenuesCapital sales$
    256.7Rental revenues114.2117.5Total revenues381.1374.2Cost of revenuesCost of goods sold147.7139.6Rental expenses48.350.1Total cost of revenues196.0189.7Gross profitCapital119.2117.1Rental65.967.4Total gross profit185.1184.5As a percentage of sales48.6%49.3%Research and development expenses15.314.8Selling and administrative expenses120.2120.0Operating profit49.649.7Other income (expense), net(1.2)(2.1)Income tax expense15.512.2Net income 32.935.4Less:  Net income attributable to noncontrolling interest-0.2Net income attributable to common shareholders$
    35.2Diluted earnings per share$
    .55Average common shares outstanding - diluted
    (thousands)62,33764,244Dividends per common share$
    .1025Non-GAAP Financial Disclosures and ReconciliationsWhile Hill-Rom reports financial results in accordance with U.S. GAAP, this press release includes non-GAAP measures. These non-GAAP measures are not in accordance with, nor are they a substitute for, GAAP measures. Hill-Rom uses the non-GAAP measures to evaluate and manage its operations and provides the information to assist investors in performing financial analysis that is consistent with financial models developed by research analysts. Investors should consider non-GAAP measures in addition to, not as a substitute for, or as superior to, measures of financial performance prepared in accordance with GAAP. Hill-Rom Holdings, Inc. and SubsidiariesRevenues - Constant Currency(Dollars in millions)Quarterly Period Ended December 312011Foreign Exchange 20112010Constant CurrencyAs ReportedImpactAdjustedAs ReportedChangeCapital sales$
    256.74.1%Rental revenues114.2-114.2117.5-2.8%Total$
    374.21.9%Acute Care$
    218.17.2%Post-Acute Care50.7-50.752.3-3.1%International 96.7(0.1)96.8103.8-6.7%Total $
    374.21.9%Hill-Rom Holdings, Inc. and SubsidiariesReconciliation: Earnings Per Share(Dollars in millions except per share data)Quarterly Period Ended December 31, 2011Quarterly Period Ended December 31, 2010Income Before Income TaxesIncome Tax ExpenseDiluted EPSIncome Before Income Taxes and NCIIncome Tax Expense Diluted EPSGAAP Earnings$
    .55Adjustments:Vendor product recall(2.1)(0.8)(0.02)---Inventory step-up and acquisition costs1.70.50.02---Adjusted Earnings$
    .55Hill-Rom Holdings, Inc. and SubsidiariesCondensed Consolidated Balance Sheets(Dollars in millions)December 31, 2011September 30, 2011AssetsCurrent AssetsCash and cash equivalents$
    224.6Trade accounts receivable, net of allowances350.7386.2Inventories, net93.995.6Other current assets71.485.3Total current assets729.9791.7Property, plant and equipment, net216.2222.8Goodwill87.087.2Other assets189.7197.4Total Assets$
    ,299.1LiabilitiesCurrent LiabilitiesTrade accounts payable$
    4.8Short-term borrowings49.0100.3Other current liabilities124.2168.9Total current liabilities236.6334.0Long-term debt50.150.8Other long-term liabilities167.4172.6Total Liabilities454.1557.4Shareholders' Equity768.7741.7Total Liabilities and Shareholders' Equity$
    ,299.1Hill-Rom Holdings, Inc. and SubsidiariesConsolidated Statements of Cash Flows(Dollars in millions) Quarterly Period Ended December 31 2011 2010 Operating ActivitiesNet income $
    35.4Adjustments to reconcile net income to net cash provided by   operating activities:Depreciation and amortization26.625.4Provision for deferred income taxes(3.6)(1.6)Gain on disposal of property, equipment leased to others,intangible assets and impairments(1.6)(0.1)Stock compensation2.52.6Excess tax benefits from employee stock plans(0.7)(3.6)Change in working capital excluding cash, current investments,current debt, acquisitions and dispositions:Trade accounts receivable34.81.7Inventories1.8(4.3)Other current assets16.511.3Trade accounts payable(1.7)(12.8)Accrued expenses and other liabilities(43.5)(31.0)Other, net(1.9)0.5Net cash provided by operating activities62.123.5Investing ActivitiesCapital expenditures and purchase of intangibles(18.6)(12.5)Proceeds on sales of property and equipment leased to others3.12.1Proceeds on investment sales and maturities-0.2Net cash used in investing activities(15.5)(10.2)Financing ActivitiesChange in short-term debt(3.8)7.0Payment of long-term debt(47.3)-Purchase of noncontrolling interest(0.7)(10.6)Payment of cash dividends(7.0)(6.5)Proceeds on exercise of options2.119.1Proceeds from stock issuance0.90.8Excess tax benefits from employee stock plans0.73.6Treasury stock acquired(1.7)(28.8)Net cash used in financing activities(56.8)(15.4)Effect of exchange rate changes on cash(0.5)-Total Cash Flows(10.7)(2.1)Cash and Cash Equivalents:At beginning of period224.6184.5At end of period$

    SOURCE Hill-Rom Holdings, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Related medicine technology :

    1. Hill-Rom Announces Preliminary Fiscal First Quarter Financial Results; Updates 2012 Financial Outlook
    2. Hill-Rom Holdings, Inc. Hosts Fiscal 2012 First Quarter Earnings Webcast
    3. Hill-Rom to Participate in the Piper Jaffray Health Care Conference
    4. Hill-Rom Reports Fiscal Fourth Quarter and Full Year Results; Provides 2012 Financial Outlook
    5. Hill-Rom to Participate in the Credit Suisse Healthcare Conference
    6. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2011 Fourth Quarter Earnings and 2012 Financial Guidance Webcast
    7. Hill-Rom Acquires Liko France and Switzerland
    8. Hill-Rom to Participate in the Morgan Stanley Global Healthcare Conference
    9. Hill-Rom Announces Fourth Quarter 2011 Dividend
    10. Hill-Rom Reports Fiscal Third Quarter Results; Updates 2011 Financial Outlook
    11. Hill-Rom Holdings, Inc. Hosts Fiscal 2011 Third Quarter Earnings Webcast
    Post Your Comments:
    (Date:5/3/2016)... -- Research and Markets has announced the ... Market Outlook 2020" report to their offering. ... technology has improved significantly in past years due to ... coming years. Many cancer drugs have been developed by ... also expected to be developed with its help. They ...
    (Date:5/3/2016)... , May 3, 2016   BIOTRONIK , ... today announced Food and Drug Administration (FDA) approval ... that provides heart failure patients with access to ... also have remote monitoring with daily automatic transmission ... heart rate in response to physiological demands. ...
    (Date:5/3/2016)... May 3, 2016 Pharmaceutical giant ... million to a woman who says its talc-based powder ... Gloria Ristesund $5 million in compensatory damages ... (Logo: ) , This ... the company. In February, the same court awarded $72 ...
    Breaking Medicine Technology:
    (Date:5/4/2016)... ... May 04, 2016 , ... All-Star Insurance ... to assist the people of their local community. The agency pledges to select ... leaders. Their hope is to bring awareness to important local causes with fundraising ...
    (Date:5/4/2016)... ... ... Dr. Elyson and Dr. Assili, dentist in Northridge , announce that ... a common dental procedure, is performed for many adolescents and young adults today. While ... of complications. By providing wisdom tooth removal surgery at their office, Dr. Elyson and ...
    (Date:5/4/2016)... , ... May 04, 2016 , ... Francesca Loparco, Co-Founder ... her life forever with a same-day LASIK procedure at Christenbury Eye Center. ... Dr. Jonathan Christenbury performed her surgery the same day as her in-office consultation and ...
    (Date:5/4/2016)... (PRWEB) , ... May 04, 2016 , ... ... all-LED multi-function small and compact tactical (6.7 inch) dual-light flashlights in models ... Vegas, model NSP-9842XL (average retail starting at $59.95) uses 2 included CR-123 batteries ...
    (Date:5/4/2016)... ... May 04, 2016 , ... Warren L. Smith M.D. , There ... UTIs, have plagued people since the beginning of recorded medical history, and in ... every year. It's not just a matter of inconvenience; bladder infections cost us billions ...
    Breaking Medicine News(10 mins):